Cited by 37

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse

Lee, Jeansun, Dieckmann, Nele M.G., Edgar, James R., Griffiths, Gillian M., Siegel, Richard M.·2018·Immunity, Inflammation and Disease

Abstract

Introduction: T cell and NK cell cytotoxicity can be mediated via the perforin/granzyme system and Fas Ligand (FasL, CD178). FasL is synthesized as a type II transmembrane protein that binds its cognate receptor Fas (CD95). Membrane‐bound FasL is expressed on the plasma membrane of activated lymphocytes and is the main form of FasL with cytotoxic activity, but whether FasL is delivered to the immune synapse along with granzyme and perforin‐containing granules is unclear. Methods: We stably expressed FasL‐fluorescent fusion proteins into human NK cells and examined the localization of FasL relative to other intracellular markers by confocal and immunoelectron microscopy, and examined the trafficking of FasL during formation of immune synapses with HLA‐deficient B cells. Results: FasL co‐localized with CD63 more strongly than perforin or Lamp1+ in cytolytic granules. Electron microscopy revealed that FasL is enriched on intraluminal vesicles (ILVs) adjacent to the dense‐core within cytolytic granules. In NK cells forming immune synapses with HLA‐deficient B cells, a portion of FasL‐containing granules re‐localize toward the immune synapse, while a distinct pool of FasL remains at the distal pole of the cell. Conclusions: Localization of FasL to intra‐luminal vesicles within cytolytic granules facilitates FasL trafficking to immune synapses and cytotoxic function in NK cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/iid3.219

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The presence of ILVs within iridosomes supports an endosomal origin or an endosomal intermediate during iridosome formation and maturation.

    “Because ILVs are a hallmark of multivesicular bodies and are commonly observed during the maturation of multiple LRO types, including melanosomes and cytotoxic granules (86–88), their presence within iridosomes supports an endosomal origin or an endosomal intermediate during iridosome formation and maturation.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. 10.1038/4779 · DOI
  2. 10.1016/S0006-291X(02)00841-0 · DOI
  3. 10.1073/pnas.91.24.11571 · DOI
  4. Oshimi Y., 1996, Involvement of Fas ligand and Fas‐mediated pathway in the cytotoxicity of human natural killer cells, J. Immunol, 157, 2909, 10.4049/jimmunol.157.7.2909 · DOI
  5. 10.1016/j.immuni.2007.03.016 · DOI
  6. 10.1016/j.immuni.2008.07.016 · DOI
  7. 10.1182/blood.V98.1.194 · DOI
  8. 10.1016/j.jaci.2012.06.011 · DOI
  9. 10.1016/j.immuni.2007.12.017 · DOI
  10. 10.1002/hep.20504 · DOI
  11. 10.1172/JCI3248 · DOI
  12. 10.1038/sj.cdd.4402175 · DOI
  13. 10.1038/nature08402 · DOI · Paper page
  14. 10.4049/jimmunol.154.8.3806 · DOI
  15. 10.1126/science.7518614 · DOI
  16. 10.1074/jbc.M107005200 · DOI
  17. Martinez‐Lorenzo M. J., 1999, Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles, J. Immunol, 163, 1274, 10.4049/jimmunol.163.3.1274 · DOI
  18. 10.1093/molehr/gah129 · DOI
  19. 10.4049/jimmunol.167.12.6736 · DOI
  20. 10.1242/jcs.114.13.2405 · DOI
  21. 10.1016/0092-8674(94)90375-1 · DOI
  22. 10.1016/1074-7613(94)90106-6 · DOI
  23. 10.1002/eji.1830240422 · DOI
  24. 10.1016/0167-5699(95)80122-7 · DOI
  25. 10.1002/eji.1830190819 · DOI
  26. 10.1084/jem.173.5.1099 · DOI
  27. 10.1083/jcb.111.6.2327 · DOI
  28. 10.1073/pnas.86.18.7128 · DOI
  29. 10.1074/jbc.M501112200 · DOI
  30. 10.1016/j.molimm.2015.02.008 · DOI
  31. 10.1084/jem.188.12.2375 · DOI
  32. 10.1034/j.1600-065X.2002.18910.x · DOI
  33. Martinez‐Lorenzo M. J., 1999, Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles, J. Immunol, 163, 1274, 10.4049/jimmunol.163.3.1274 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lee, J., Dieckmann, N. M. G., Edgar, J. R., Griffiths, G. M., & Siegel, R. M.
Affiliations
  • CIMR, Department of Medicine Cambridge University Cambridge UK
  • Immunoregulation Section, Autoimmunity Branch, National Institutes of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health Bethesda Maryland USA
Venue
Immunity, Inflammation and Disease
Publisher
Wiley
Published
2018-04-11
Volume
6
Issue
2
Pages
312-321
ISSN
2050-4527
Cited by
37
References
1
Language
en
Funders
  • Wellcome Trust (103930)
  • Cambridge Institute for Medical Research, University of Cambridge (100140)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review